Home/Talus Bioscience/Christopher Joyce, MBA
CJ

Christopher Joyce, MBA

VP of Business Development

Talus Bioscience

Talus Bioscience Pipeline

DrugIndicationPhase
TBXTChordoma, Lung CancerPre-clinical
NONO/AR–V7Castration–Resistant Prostate CancerPre-clinical
Undisclosed Transcription FactorSolid TumorDiscovery